Chime Biologics Announces Strategic Collaboration with Beijing Libang Pharmaceutical on Global Blinatumomab Biosimilar Program
Article Date
December 10, 2025
This article is featured on another website.
Go to article
January 12, 2026
Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies
January 12, 2026
Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies
January 28, 2026
Navigating Clinical Trials in the Philippines and Malaysia: Insights and Opportunities
Due to a combination of large, diverse populations, effective healthcare infrastructure, and evolving regulatory and…
January 28, 2026
Navigating Clinical Trials in the Philippines and Malaysia: Insights and Opportunities
Due to a combination of large, diverse populations, effective healthcare infrastructure, and evolving regulatory and…